Blue Bird Beats Q3, Raises Full-Year EBITDA Guidance as Tariff Pricing Holds

What happened

Blue Bird reported fiscal Q3 2026 revenue of $517 million and adjusted EBITDA of $71 million, exceeding its own guidance and raising the full-year adjusted EBITDA outlook. The beat suggests the company’s strategy of locking tariff charges on new orders through June 2026 is sustaining unit margins despite procurement cost pressure. The raised guidance directly addresses the key risk flagged in earlier filings—that tariff pass-through might falter as orders convert to deliveries. With the pricing lock period now expiring, the next focus shifts to whether order intake and backlog can hold without that shield. The result marginally upgrades the investment posture from WAIT to a more neutral HOLD, though valuation and post-lock uncertainty keep a bull case from fully forming.

Implication

The Q3 beat reinforces the narrative that Blue Bird can price through tariff headwinds while maintaining delivery momentum. The raised EBITDA outlook implies margin durability at least through fiscal 2026, directly addressing the WAIT rating’s primary concern. With the tariff lock period ending June 2026, the upcoming quarters will reveal whether order intake holds without pricing guarantees. For now, the stock appears closer to its base-case value, reducing the appeal of a WAIT stance. However, entry remains unattractive until further visibility emerges on post-lock demand and any potential margin mean reversion.

Thesis delta

The Q3 beat and raised guidance materially de-risk the bear case that tariff pass-through would erode margins before June 2026. The WAIT thesis centered on needing evidence of margin durability and backlog stability; this print provides that evidence for the near term. However, the thesis remains incomplete until the company demonstrates resilient demand and pricing power beyond the tariff-lock window, so the critical juncture is now the post-June 2026 order cycle.